Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Is blood pTau a reliable indicator of the CSF status? A narrative review

Antonioni A, Raho EM, Di Lorenzo F.

Neurol Sci. 2024 Jun;45(6):2471-2487. doi: 10.1007/s10072-023-07258-x. Epub 2023 Dec 22.

An overview on microglial origin, distribution, and phenotype in Alzheimer's disease

Islam R, Choudhary H, Rajan R, Vrionis F, Hanafy KA.

J Cell Physiol. 2024 Jun;239(6):e30829. doi: 10.1002/jcp.30829. Epub 2022 Jul 13.

Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target

Mandlik DS, Mandlik SK, S A.

Int J Neurosci. 2024 Jun;134(6):603-619. doi: 10.1080/00207454.2022.2130297. Epub 2022 Oct 10.

Validity and reliability of the Turkish version of the ALBA screening instrument for Lewy body dementia in older adults

Kaya D, Yesil Gurel BH, Akpinar Soylemez B, Dost FS, Dokuzlar O, Mutlay F, Ates Bulut E, Petek K, Golimstok AB, Isik AT.

Appl Neuropsychol Adult. 2024 Nov-Dec;31(6):1457-1462. doi: 10.1080/23279095.2022.2142793. Epub 2022 Nov 4.

Opportunities and challenges for the development of M(1) muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

Nguyen HTM, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A, Valant C.

Br J Pharmacol. 2024 Jul;181(14):2114-2142. doi: 10.1111/bph.15982. Epub 2022 Dec 4.

Interventions focusing on learning pre-transfer wheelchair manipulation in a patient with severe Alzheimer's disease: a case report

Nakagawa K, Kanai S, Kitakaze S, Okamura H.

Physiother Theory Pract. 2024 May;40(5):1091-1099. doi: 10.1080/09593985.2022.2149287. Epub 2022 Nov 21.

A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research

Esiaka D, Yarborough CC, Fausto BA, Gluck MA.

Community Health Equity Res Policy. 2024 Jul;44(4):419-428. doi: 10.1177/0272684X221118493. Epub 2022 Sep 18.

TREM2 R47H variant and risk for Alzheimer's disease: assessment in a Greek population and updated meta-analysis

Rikos D, Siokas V, Mentis AA, Aloizou AM, Liampas I, Tsouris Z, Peristeri E, Stamati P, Hadjigeorgiou GM, Dardiotis E.

Int J Neurosci. 2024 Jul;134(7):786-794. doi: 10.1080/00207454.2022.2150844. Epub 2022 Dec 6.

Advancement in Analytical Techniques for Determining the Activity of β-Site Amyloid Precursor Protein Cleaving Enzyme 1

Fan J, Wei X, Dong H, Zhang Y, Zhou Y, Xu M, Xiao G.

Crit Rev Anal Chem. 2024;54(6):1797-1809. doi: 10.1080/10408347.2022.2132812. Epub 2022 Oct 13.

Intelligent assistive technology devices for persons with dementia: A scoping review

Dada S, van der Walt C, May AA, Murray J.

Assist Technol. 2024 Sep;36(5):338-351. doi: 10.1080/10400435.2021.1992540. Epub 2022 Jan 25.

CT perfusion appearance of CADASIL coma

Merli E, Zini A, Gentile M.

Acta Neurol Belg. 2024 Jun;124(3):1005-1007. doi: 10.1007/s13760-022-02017-9. Epub 2022 Jul 13.

Anesthesia and dementia: An up-to-date review of the existing literature

Tsolaki M, Sia E, Giannouli V.

Appl Neuropsychol Adult. 2024 Mar-Apr;31(2):181-190. doi: 10.1080/23279095.2022.2110871. Epub 2022 Aug 18.

Naming as a window to word retrieval changes in healthy and pathological ageing: Methodological considerations

Martínez-Ferreiro S.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):68-83. doi: 10.1111/1460-6984.12827. Epub 2022 Dec 12.

The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort

Puig-Pijoan A, García-Escobar G, Fernández-Lebrero A, Manero-Borràs RM, Sánchez-Benavides G, Navalpotro-Gómez I, Cascales Lahoz D, Suárez-Calvet M, Grau-Rivera O, Boltes Alandí A, Pont-Sunyer MC, Ortiz-Gil J, Carrillo-Molina S, López-Villegas D, Abellán-Vidal MT, Martínez-Casamitjana MI, Hernández-Sánchez JJ, Peña-Casanova J, Roquer J, Padrós Fluvià A, Puente-Périz V.

Neurologia (Engl Ed). 2024 Nov-Dec;39(9):756-765. doi: 10.1016/j.nrleng.2022.05.002. Epub 2022 Aug 9.

Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)

Cohen LM, Ash E, Outen JD, Vandrey R, Amjad H, Agronin M, Burhanullah MH, Walsh P, Wilkins JM, Leoutsakos JM, Nowrangi MA, Harper D, Rosenberg PB, Forester BP.

Int Psychogeriatr. 2024 Dec;36(12):1245-1250. doi: 10.1017/S1041610221001150. Epub 2021 Oct 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias